AUA

Shorts

Jenny N. Guo, MD, on key BPH takeaways from AUA 2026
0:36
Jenny N. Guo, MD, on key BPH takeaways from AUA 2026
5 months ago
by
Jenny N. Guo, MD
Kari A.O. Tikkinen, MD, PhD, discusses tranexamic acid in urology
0:33
Kari A.O. Tikkinen, MD, PhD, discusses tranexamic acid in urology
6 months ago
by
Kari A.O. Tikkinen, MD, PhD
Nicole L. Miller, MD, FACS, on advances in evaluating and treating LUTS
1:38
Nicole L. Miller, MD, FACS, on advances in evaluating and treating LUTS
6 months ago
by
Nicole L. Miller, MD, FACS
Catherine A. Matthews, MD, FACS, shares takeaways from the INTIBIA Pivotal Trial
0:32
Catherine A. Matthews, MD, FACS, shares takeaways from the INTIBIA Pivotal Trial
6 months ago
by
Catherine A. Matthews, MD, FACOG, FACS, FPMRS
Michael S. Cookson, MD, on darolutamide’s safety profile
0:22
Michael S. Cookson, MD, on darolutamide’s safety profile
6 months ago
by
Michael S. Cookson, MD, MMHC, FACS
Jonathan D. Harper, MD, on increasing fluid intake to prevent recurrent stones
0:41
Jonathan D. Harper, MD, on increasing fluid intake to prevent recurrent stones
6 months ago
by
Jonathan D. Harper, MD
Nima Almassi, MD, on shared decision-making around bladder-preserving treatment options
0:57
Nima Almassi, MD, on shared decision-making around bladder-preserving treatment options
6 months ago
by
Nima Almassi, MD
Kathryn H. Gessner, MD, PhD, on the most exciting current developments in bladder cancer
0:49
Kathryn H. Gessner, MD, PhD, on the most exciting current developments in bladder cancer
6 months ago
by
Kate Gessner, MD, PhD
Joshua J. Meeks, MD, PhD, on the need for recombinant BCG
0:18
Joshua J. Meeks, MD, PhD, on the need for recombinant BCG
6 months ago
by
Joshua J. Meeks, MD, PhD
Nicole L. Miller, MD, FACS, on what she tells patients after BPH treatment failure
0:39
Nicole L. Miller, MD, FACS, on what she tells patients after BPH treatment failure
6 months ago
by
Nicole L. Miller, MD, FACS

Latest Content

“The results of the BRAVO study performed within the VA health care system showed significant decreases in the risk of recurrence and progression, as well as the potential for improved overall survival in patients who received a BLC compared to patients who received WLC only,” says Stephen B. Williams, MD, MBA, MS, FACS, FACHE.